当前蛋白质消费风头正劲，这为鸡蛋供应商Cal-Maine Foods带来利好。该公司首席执行官Sherman Miller向投资者强调，鸡蛋始终是价格亲民的蛋白质选择。与此同时，GLP-1药物使用者愈发青睐营养密集型食品，年轻消费群体将鸡蛋视为日常必需品，而购物者也更倾向于升级购买价格更高、品质更优的鸡蛋品种。
Miller在与分析师的电话会议中表示：“简而言之，鸡蛋在健康性、便利性和品质方面表现突出，这种综合优势正在重塑行业增长格局，我们相信这正好契合我们的核心优势。”
（注：本文根据公开市场信息整理，不构成任何投资建议）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.